Advisory: Research alert on Checkpoint Therapeutics Inc withdrawn
15/02/2023 08:15
Feb 15 (Reuters) - A research alert on Goldman Sachs initiating coverage on Checkpoint Therapeutics Inc CKPT.O is wrong and has been withdrawn. The brokerage initiated coverage on Check Point Software Technologies Ltd CHKP.O , an unrelated company. For the correct alert click here. STORY_NUMBER: FWN34V1OB STORY_DATE: 15/02/2023 STORY_TIME: 07:52:32 ((Bangalore.newsroom@thomsonreuters.com))
Recent news on Checkpoint Therapeutics
See all newsCheckpoint Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Checkpoint Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview
Checkpoint Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary
Checkpoint Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview
Street View -India's Sun Pharma buying Checkpoint boosts its specialty portfolio, analysts say